A synthetic peptide for use as a blocking control in assays to test for specificity of MMP19 antibody, Alternative Names: MMP19 control peptide, MMP19 antibody Blocking Peptide, Anti-MMP19 Blocking Peptide, MMP-19 Blocking Peptide, MMP 19 Blocking Peptide, Matrix Metallopeptidase 19 Blocking Peptide, MMP19, MMP-19, MMP 19, MMP-19 Blocking Peptide, MMP 19 Blocking Peptide
Aufreinigung
The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
MMP19
(Matrix Metallopeptidase 19 (MMP19))
Hintergrund
Proteins of the matrix metalloproteinase (MMP) family are involved in the Breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling. They are also involved in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The function of the protein encoded by this gene has not been determined. This gene was previously referred to as MMP18 but has been renamed matrix metalloproteinase 19 (MMP19).